Dr. Lah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Executive Park Dr NE
Atlanta, GA 30329Phone+1 404-778-3444Fax+1 404-712-0278
Education & Training
- Emory University School of MedicineResidency, Neurology, 1993 - 1996
- Emory University School of MedicineInternship, Internal Medicine, 1992 - 1993
- Ohio State University College of MedicineClass of 1992
- Ohio State UniversityPh.D., Cell Biology and Neuroscience, 1992
- Duke UniversityB.S., Zoology, 1984
Certifications & Licensure
- GA State Medical License 1996 - 2025
- NC State Medical License 2020 - 2022
- AL State Medical License 2020 - 2020
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Outstanding Postdoc Mentor Award Emory University, 2012
- Tomorrow’s Leader in Alzheimer’s Disease Award Int’l Conference on AD, Chicago, IL, 2008
- Research Award for Clinical Trainees National Institutes of Health, 1993
- Join now to see all
Clinical Trials
- Effects of Atomoxetine in Mild Cognitive Impairment Start of enrollment: 2012 Mar 01
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- Join now to see all
Publications & Presentations
PubMed
- Accelerated model-based T1, T2* and proton density mapping using a Bayesian approach with automatic hyperparameter estimation.Shuai Huang, James J Lah, Jason W Allen, Deqiang Qiu
Magnetic Resonance in Medicine. 2025-02-01 - Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.Maureen Okafor, Zhiyi Yang, Kayci L Vickers, Katherine Sanders, Najé Simama
Journal of Alzheimer's Disease. 2024-12-11 - Receptive vocabulary is superior to education level to account for Black and White neuropsychological performance discrepancies.Felicia C Goldstein, John J Hanfelt, Taylor A James, James J Lah, David W Loring
Journal of the International Neuropsychological Society. 2024-12-03
Journal Articles
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humansBakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM,..., Proc Natl Acad Sci U S A, 3/1/2012
- Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complexLane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, Tanzi RE, Attie AD, Gandy S, J Neurosci, 9/1/2010
Press Mentions
- Newly Approved Alzheimer's Disease Drug Gives Hope to WYFF News 4'S Geoff HartJune 10th, 2021
- Can Flickering Light and Sound Treat Alzheimer’s?June 8th, 2021
- Cajoling Brain Cells to DanceJune 4th, 2021
- Join now to see all
Grant Support
- Clinical CoreNational Institute On Aging2010–2012
- APOE Receptor LR11 In Alzheimer'S EtiopathogenesisNational Institute On Aging2004–2007
- Structure And Function Of Alzheimers Disease ProteinsNational Institute Of Neurological Disorders And Stroke1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: